ruxolitinib
incyte
['true-v,(-true-v1),(-true-v2)', 'vitiligo', 'incyte']
#news: new 104-week vitiligo data from our phase 3 true-v clinical trial program featured as a late-breaker at the annual meeting. learn more. #aad2023
Incyte’s official Twitter. Ready to Solve On. See our Community Guidelines: https://t.co/DD2VZaemus